Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Krystal Biotech (KRYS) Current Assets: 2021-2025

Historic Current Assets for Krystal Biotech (KRYS) over the last 5 years, with Sep 2025 value amounting to $925.6 million.

  • Krystal Biotech's Current Assets rose 29.79% to $925.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $925.6 million, marking a year-over-year increase of 29.79%. This contributed to the annual value of $742.0 million for FY2024, which is 26.22% up from last year.
  • Latest data reveals that Krystal Biotech reported Current Assets of $925.6 million as of Q3 2025, which was up 10.02% from $841.3 million recorded in Q2 2025.
  • In the past 5 years, Krystal Biotech's Current Assets registered a high of $925.6 million during Q3 2025, and its lowest value of $345.8 million during Q3 2021.
  • For the 3-year period, Krystal Biotech's Current Assets averaged around $662.1 million, with its median value being $682.8 million (2024).
  • Per our database at Business Quant, Krystal Biotech's Current Assets fell by 18.85% in 2023 and then skyrocketed by 69.44% in 2024.
  • Quarterly analysis of 5 years shows Krystal Biotech's Current Assets stood at $442.3 million in 2021, then dropped by 13.22% to $383.8 million in 2022, then surged by 53.19% to $587.9 million in 2023, then climbed by 26.22% to $742.0 million in 2024, then increased by 29.79% to $925.6 million in 2025.
  • Its last three reported values are $925.6 million in Q3 2025, $841.3 million for Q2 2025, and $766.8 million during Q1 2025.